NIH Halts Nationwide Study of Hormonal Drugs

Blue Shield Expands Coverage to Cross-Border Dependents

Health Care
by Marion Webb, Senior Staff Writer

Researchers abruptly halted the nation's largest study of hormone replacement therapy in healthy menopausal women because the drugs increased the risk of breast cancer, coronary heart disease, stroke and pulmonary embolism...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 52 weekly issues
  • Subscriber-only digital content every business day, plus full access to archives
  • Book of Lists — the most comprehensive business resource in San Diego
  • San Diego 500 — influential business leaders you need to know
Yours for only $99